-
Information
Santen to Present Latest Data on MicroShunt at 14th EGS Congress
-
Information
Ciclosporin Topical Ophthalmic Emulsion, 0.1% in the Treatment of Severe Vernal Keratoconjunctivitis in Patients Ages 4-18, has been added to China's third batch of Overseas New Drugs Urgently Needed in Clinical Settings, compiled by the NMPA
-
Information
Santen to Present Latest Data on Omidenepag Isopropyl and Microshunt at AAO 2020 Virtual
-
Press Release
IR News
Santen Reports the 2nd Quarter Fiscal 2020 Consolidated Performance
-
Press Release
IR News
Santen releases LENTIS Comfort Toric in Japan, a multifocal IOL covered under the Japanese health insurance program for cataract patients with astigmatism
-
Press Release
IR News
Santen and Aerie Conclude Exclusive License Agreement for Rhopressa and Rocklatan in Japan and Several Other Asian Countries
-
Press Release
IR News
Santen, JBFA and IBF Foundation Form Long-term Partnership for an Inclusive Society ~An innovative, 10-year partnership agreement that aims to achieve long-term stability of sports management for the advancement of diversity and inclusion in our society~
-
Information
Santen Announces U.S. FDA Filling Acceptance of New Drug Application(NDA) for Cyclosporine Topical Ophthalmic Emulsion, 0.1% in the Treatment of Severe Vernal Keratoconjunctivitis in Patients Ages 4-18
-
Press Release
IR News
Notice on the Establishment of Holding Company in China
-
Press Release
IR News
Santen and Orbis International Announce Long-term Partnership to Tackle the Increasing Burden of Eye Diseases
-
Information
Santen China won the Best Ophthalmic Public Education Award at the 2020 Chinese Ophthalmologist Association (COA) Annual Conference
-
Information
Integrated Report Santen Report 2020 has been published
-
Information
Announcing Addition of Third Building to Shiga Product Supply Center's Site
-
Press Release
IR News
Santen and U.S. Ophthalmic Company Eyevance Enters into Share Purchase Agreement
-
Press Release
IR News
Notice of Corporate Officer Appointments
-
Information
Santen, Verily Announce Joint Venture
-
Press Release
~Building an Inclusive Society~Santen Decides to Offer Special Sponsorship for Continued Activities of Men's and Women's National Blind Football Teams
-
Press Release
~Building an Inclusive Society~Santen and International Blind Sports Federation Forges Partnership through Blind Sports
-
Information
Corporate Social Responsibility (CSR) page on our website has been updated
-
Press Release
IR News
Santen Reports the 1st Quarter Fiscal 2020 Consolidated Performance
-
Press Release
IR News
Santen and RVL Pharmaceuticals, Inc., an Osmotica Company, Enter into an Exclusive License Agreement in Japan, Asia, and EMEA for RVL-1201, a First-in-Class Treatment for Acquired Blepharoptosis
-
Press Release
IR News
Notice on the Completion of Disposal of Treasury Shares Under Restricted Stock-Linked Remuneration Program
-
Press Release
IR News
Santen Announces U.S. FDA Acceptance of Premarket Approval (PMA) Application for DE-128 (MicroShunt) for Review
-
Press Release
IR News
Santen Introduces its New Corporate Brand Name Notation and Corporate Slogan Aiming to Grow on a Globally, Going beyond the Pharmaceutical Industry
-
Press Release
IR News
Announcement of New Vision Aiming to Resolve Social Issues Related to the Eye Health of People around the World
-
Press Release
IR News
Santen and Singapore's Health-tech Start-up, Plano Form a Strategic Alliance to Tackle the Global Burden of Myopia
-
Press Release
IR News
Notice on the Disposal of Treasury Shares Under Restricted Stock-Linked Remuneration Program
-
Information
Santen's Proposed New Working Styles under the New Normal
-
Press Release
IR News
Santen and Orbis International Join Forces to Expand Access to Training for Eye Care Professionals through Telemedicine Platform
-
Information
Announcement of New Long-Term Vision
-
Press Release
IR News
Providing Eye Care Information to Resolve Problems Caused by Excessive Screen Time
-
Press Release
IR News
Bayer Yakuhin and Santen launch 'EYLEA Intravitreal Injection KIT 40mg/mL', pre-filled syringe of intravitreal VEGF Inhibitor EYLEA
-
Information
Santen's Measures to Combat Novel Coronavirus Infections (COVID-19) (No. 3)
-
Press Release
IR News
Notice of Board of Director and Corporate Auditor Nominations
-
Press Release
IR News
Santen Reports Fiscal 2019 Consolidated Performance
-
Press Release
IR News
Santen and jCyte Conclude an Exclusive Licensing Contract in Japan, Asia and Europe for the jCell Therapy Program for Retinitis Pigmentosa
-
Press Release
IR News
Santen, Together with Nonprofit Organization, Japan Blind Football Association, to Support People with Visual Impairments Facing the COVID-19 Pandemic
-
Press Release
IR News
Santen Introduces Eco-Friendly Biomass Plastic Eyedrop Bottles
-
Information
Santen Pharmaceutical measures to combat the disease caused by the novel coronavirus (COVID-19)
-
Press Release
IR News
Intravitreal VEGF Inhibitor EYLEA approved as a Treatment of Neovascular Glaucoma (NVG), its fifth indication
-
Information
Santen's Measures to Combat Novel Coronavirus Infections (COVID-19) (No. 2)
-
Press Release
IR News
Notice of Corporate Officer Appointments
-
Press Release
IR News
Santen and TRACON Discontinue Development of DE-122 for Wet Age-Related Macular Degeneration
-
Press Release
IR News
Santen to Conduct Activities to Raise Awareness on Importance of Early Detection and Treatment of Glaucoma during World Glaucoma Week (March 8-14, 2020)
-
Information
Santen's Measures to Combat Novel Coronavirus Infections (COVID-19) (No. 1)
-
Information
Beware of Suspicious E-mails and Messages on Social Media Claiming to be from Santen Pharmaceutical Co., Ltd.
-
Press Release
IR News
Notice of personnel change
-
Press Release
IR News
Santen and Verily Establish Joint Venture to Develop and Commercialize Unique Ophthalmic Devices
-
Press Release
IR News
Santen Reports the 3rd Quarter Fiscal 2019 Consolidated Performance
-
Press Release
IR News
Santen Pharmaceutical Selected as Title Sponsor of IBSA Blind Football World Grand Prix 2020!
-
Press Release
IR News
Santen Pharmaceutical Signs Partnership Agreement with ITU Supporting ITU and WHO initiative 'Be He@lthy, Be Mobile' in Ophthalmology
-
Press Release
IR News
Santen Announces the Construction of China Second Plant
